论文部分内容阅读
为了观察放疗对子宫内膜癌的影响。对我院1987年～1990年72例接受放疗的子宫内膜癌患者进行分析。根据1971年FIGO标准，Ⅰ期24例、Ⅱ期41例、Ⅲ期7例。病理分类：腺癌58例、腺鳞癌6例、透明细胞癌2例。年龄：35～76岁，平均年龄57．96岁。治疗方法：全盆大野照射，盆腔中平面剂量为DT40GY～50GY，腔内治疗X点剂量20～40GY，A点剂量20GY～30GY。5例单纯体外照射、14例单纯腔内、53例体外加腔内。38例患者放疗后行全子宫及双侧附件切除，术后病理证实，部分病例无肿瘤残存。腔内放疗作为全盆外照后的补充放疗能有效地控制子宫内膜肿瘤。总五年存活率为52．6％，Ⅰ～Ⅱ期五年存活率为：Ⅰ期58％、Ⅱ期51．14％、Ⅲ期28．77％。单纯放疗可适用于Ⅰ、Ⅱ期子宫内膜癌不宜手术的患者。对病期较晚、手术不能切除干净的晚期患可行全量放疗，然后争取行子宫及双侧附件切除。为了提高单纯放疗疗效，在放射治疗前临床医生应尽可能全面的掌握肿瘤的信息。
In order to observe the impact of radiotherapy on endometrial cancer. In our hospital from 1987 to 1990, 72 cases of endometrial cancer patients undergoing radiotherapy were analyzed. According to 1971 FIGO standard, 24 cases of stage Ⅰ, 41 cases of stage Ⅱ, 7 cases of stage Ⅲ. Pathological classification: adenocarcinoma in 58 cases, adenosquamous carcinoma in 6 cases, 2 cases of clear cell carcinoma. Age: 35 ~ 76 years old, average age 57.96 years old. Treatment: All the big field radiation, pelvic mid-plane dose of DT40GY ~ 50GY, endoscopic treatment of X dose 20 ~ 40GY, A dose of 20GY ~ 30GY. 5 cases of simple external irradiation, 14 cases of simple intracavitary, 53 cases of external plus cavity. Thirty-eight patients underwent radical hysterectomy and bilateral attachment resection. Postoperative pathology confirmed that there were no tumor residues in some cases. Endovascular radiotherapy as an extra-complete basin after radiotherapy can effectively control endometrial cancer. The total five-year survival rate was 52.6%. The five-year survival rates of stage Ⅰ-Ⅱ were 58% in stage Ⅰ, 51.14% in stage Ⅱ and 28.77% in stage Ⅲ. Simple radiotherapy can be applied to Ⅰ, Ⅱ endometrial cancer should not be surgery patients. The later stage of disease, surgery can not be removed with a clean late feasible full dose of radiotherapy, and then strive to line the uterus and bilateral attachment resection. In order to improve the efficacy of radiotherapy alone, before radiotherapy clinicians should grasp the tumor information as completely as possible.